TSEM

Business Context and Reporting Period

Company: Tower Semiconductor Ltd.
Filing Type: Form 20-F (Annual Report)
Reporting Period: Fiscal year ended December 31, 2006
Business Overview: Tower is an independent specialty foundry based in Israel, manufacturing semiconductor integrated circuits (ICs) on silicon wafers. The company operates two facilities: Fab 1 (150-mm wafers, 1.0 to 0.35-micron geometries) and Fab 2 (200-mm wafers, 0.18 to 0.13-micron geometries). Tower focuses on specialized markets including CMOS image sensors, embedded flash, mixed-signal, and RF CMOS technologies.

Key Financial Metrics (Year Ended Dec 31, 2006)

Note: Financial statements are prepared under Israeli GAAP. Significant reconciling items to US GAAP include the treatment of debt restructuring and convertible debentures.

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased 83.8% to $187.4 million, driven by an expanded customer base and higher wafer shipment volumes, offsetting the absence of $8 million in joint development agreement revenue recorded in 2005.
• Improved Gross Loss: Gross loss narrowed to $80.0 million from $136.4 million, attributed to revenue growth and cost reduction measures.
• Debt Restructuring Gain: A one-time gain of $80.1 million was recorded under Israeli GAAP due to the September 2006 amendment of the credit facility with banks. Under US GAAP, this was treated as a troubled debt restructuring with no gain recognized, resulting in a significantly higher net loss ($167.9 million).
• Financing Expenses: Net financing expenses increased to $48.1 million from $35.7 million, primarily due to new convertible debentures and currency fluctuations (NIS weakening against the USD).
• Equity Position: Shareholders' equity turned positive under Israeli GAAP ($133.0 million) due to the debt restructuring gain and capital note issuances, though it remained significantly lower under US GAAP ($39.5 million).

Guidance, Outlook, Risks, and Unusual Items

Outlook and Capital Needs

• Fab 2 Ramp-Up: The company is implementing a plan to ramp Fab 2 capacity to 24,000 wafers per month. Full capacity (approx. 40,000 wafers/month) is estimated to require an additional $120 million in funding.
• Liquidity: As of the filing date, the company expects sufficient liquidity through the end of 2007, contingent on the successful registration of securities issued in a June 2007 private placement ($40 million held in escrow).

Key Risks and Contingencies

• Investment Center Grants: The company failed to complete the required $1.25 billion investment in Fab 2 by the end of 2005. While management believes repayment of the ~$165 million in grants received is improbable, the Israeli Investment Center could demand repayment if a new expansion program is not approved.
• Debt Covenants: The company must comply with strict financial ratios and covenants under its amended credit facility. Failure to comply could trigger immediate repayment of approximately $369 million in bank debt.
• Customer Concentration: Revenue is heavily concentrated; in 2006, seven significant customers accounted for the majority of sales, with the largest contributing 23%.
• Operating Losses: The company has a history of operating losses and expects to continue operating at a loss for the foreseeable future due to high fixed costs and depreciation.

Unusual Items

• Accounting Differences: The $80 million gain on debt restructuring recognized under Israeli GAAP is excluded under US GAAP, creating a material divergence in reported net income.
• Convertible Debentures: Significant portions of convertible debentures are classified as liabilities under US GAAP due to embedded derivatives, reducing reported equity compared to Israeli GAAP.

Investor Verification Checklist

• US GAAP vs. Israeli GAAP: Verify the impact of the $80 million debt restructuring gain exclusion on the true economic loss and equity position under US GAAP.
• Investment Center Status: Confirm the status of negotiations with the Israeli Investment Center regarding the new expansion program and the risk of grant repayment.
• Debt Covenant Compliance: Review the specific financial ratios required by the amended credit facility and the company's current compliance status to assess default risk.
• Funding for Fab 2: Assess the certainty of the $40 million escrow release and the feasibility of raising the additional ~$120 million required for full Fab 2 capacity.
• Customer Concentration: Evaluate the dependency on top customers (SanDisk, Alliance, Macronix) and the risk of order cancellations or volume reductions.